58 results
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. Our goal is to extend the benefits of cancer … ) will most often restrict high-cost drugs, drugs with limited or no survival benefits, and drugs deemed to be at high risk for widespread off-label use
8-K
EX-10.2
SHPH
Shuttle Pharmaceuticals Holdings Inc
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
taking into account the relative benefits received by the Company on the one hand and BSL on the other, from the transaction or proposed transaction … the relative benefits received by the Company on the one hand and BSL on the other, but also the relative fault of the Company and BSL; provided
8-K
EX-10.1
thjo45ar 1hzzaf6q1
5 Feb 24
Entry into a Material Definitive Agreement
4:25pm
8-K
EX-99.1
9p1h7u op
14 Nov 23
Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update
12:00am
8-K
EX-99.1
96pg1sb qs
30 Oct 23
Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
5:14pm
424B3
hlylr t5yx3me
24 Aug 23
Prospectus supplement
2:00pm
DEF 14C
nv250g0 r3m5124dng82
16 Jun 23
Information statement
6:30am
PRE 14C
zon07i
5 Jun 23
Preliminary information
4:29pm
10-Q
29zpn9likd
14 Nov 22
Quarterly report
5:21pm
DRS
nhdvyyf
29 Sep 22
Draft registration statement
12:00am
424B4
ysamku
31 Aug 22
Prospectus supplement with pricing info
6:16am